Clinical trial · Interventional
Feasibility of Monitoring Cancer Patients With a Smart T-shirt: Protocol for the OncoSmartShirt Study
NCT05235594CI-TRIAL-00070870completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study will assess the feasibility of using the ChronolifeTM smart t-shirt for home monitoring of vital parameters in cancer patients during their treatment course. This study will bring new insights to how wearables and biometric data can be used as a part of symptom recognition in cancer patients during treatment course in the quest of increasing patients' quality of life.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Wearable sensor | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Experimental: Smart shirt
- description
- The research intervention is, for all twenty patients, to wear a smart t-shirt connected to a smart phone throughout the day (preferably 8 hours pr day) for 2 weeks.
- interventionNames
- Device: Wearable sensor
Primary outcomes (1)
- measure
- Number of participants who could wear the smart t-shirt preferably 8 hours pr. day during the three weeks study period
- timeFrame
- 2 weeks
- description
- To assess the feasibility of using the ChronolifeTM smart t-shirt based on the completion rate which is defined as the number of included patients using the smart t-shirt at least 12 hours pr. day during the three weeks study period.
Secondary outcomes (1)
- measure
- Technical feasibility
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Danish cancer patients ≥18 years in antineoplastic treatment at Department of Oncology Rigshospitalet Denmark * Both patients in curative and palliative care will be eligible * 10 cancer patients under 39 years * 10 cancer patients over 65 years * Able to read and speak Danish Exclusion Criteria: * Serious cognitive deficits
References
Publications (2)
- DERIVEDSteen-Olsen EB, Pappot H, Hjerming M, Hanghoej S, Hollander-Mieritz C. Monitoring Adolescent and Young Adult Patients With Cancer via a Smart T-Shirt: Prospective, Single-Cohort, Mixed Methods Feasibility Study (OncoSmartShirt Study). JMIR Mhealth Uhealth. 2024 May 1;12:e50620. doi: 10.2196/50620. PMID 38717366
- DERIVEDSteen-Olsen EB, Pappot H, Green A, Langberg H, Hollander-Mieritz C. Feasibility of Monitoring Patients Who Have Cancer With a Smart T-shirt: Protocol for the OncoSmartShirt Study. JMIR Res Protoc. 2022 Oct 3;11(10):e37626. doi: 10.2196/37626. PMID 36190744